119-HR-8875 Investigative Journalist Impact Analysis

Summary

What the bill does. H.R. 8875, the Improving Home Dialysis Act of 2026, would (1) cover staff‑assisted home dialysis “respite care” during a temporary period when a home patient cannot dialyze independently, and (2) cover “renal mental health services” during the first 60 days after a patient starts home dialysis—both as self‑care home‑dialysis support services under Medicare. It caps respite at 20 sessions per year and mental‑health visits at 4 sessions in that 60‑day window, and it specifies qualified personnel and credential standards by cross‑reference to 42 CFR 494.140 and 494.90. [1]U.S. House of Representatives — H.R. 8875 (IH) – Improving Home Dialysis Act of…

How it pays. The bill instructs CMS to make add‑on payments per session: respite at 100% of the 2025 home/self‑dialysis training add‑on (75% in non‑rural areas) and renal mental‑health services at 50% (25% in non‑rural areas). Both add‑ons are explicitly not budget‑neutral. In 2025, CMS describes the home/self‑dialysis training add‑on policy and materials; Federal Register materials reference a $95.60 per‑treatment training add‑on figure used in rulemaking context. [1]U.S. House of Representatives — H.R. 8875 (IH) – Improving Home Dialysis Act of…

Process status. On May 21, 2026, the House Ways & Means Committee ordered H.R. 8875 favorably reported, as amended, by a 28–13 vote. [2]U.S. House of Representatives — Ways & Means Committee – Votes of the Committee…

Economic Effects

• Medicare outlays: Because the new add‑ons are “not budget neutral,” aggregate ESRD spending would rise commensurate with uptake of respite and early mental‑health sessions. The per‑session base is tied to the CY2025 home/self‑dialysis training add‑on (rulemaking materials reference $95.60), multiplied by 100%/50% (rural) or 75%/25% (non‑rural) and any wage adjustments. [1]U.S. House of Representatives — H.R. 8875 (IH) – Improving Home Dialysis Act of…
• Provider revenue and behavior: ESRD PPS already bundles most dialysis costs and includes a home‑training add‑on; layering new add‑ons could improve margins for home‑programs—especially in rural facilities at 100% rates—potentially expanding staffing to support home patients. However, the ETC Model’s early evaluation found no differential growth in home dialysis in model vs. comparison areas through 2022, suggesting payment incentives alone may not rapidly shift modality mix. [3]cms.gov
• Patient financial exposure: Medicare covers dialysis services/supplies at home; beneficiary cost‑sharing would apply to these added services unless otherwise offset (e.g., MA plans/Medigap). Net out‑of‑pocket effects depend on plan design. [4]Medicare.gov (CMS) — Medicare.gov – Dialysis services & supplies coverage (home…
• System‑wide cost substitution: If respite/early psychosocial care reduces technique failure, hospitalizations, or transitions back to in‑center HD, net costs could fall; current evidence shows modest HRQoL improvements with psychosocial interventions but mixed or limited signals on utilization or survival. Policymakers should not bank savings absent stronger causal evidence. [5]American Journal of Kidney Diseases (via PMC) — Health‑Related Quality of Life…

Illustrative budget sensitivity (not a forecast): If 100,000 home‑dialysis patients each used 2 respite sessions at a $95.60 base (non‑rural 75% assumption → $71.70) and 2 mental‑health sessions at 25% ($23.90), gross add‑ons ≈ $19.1M (ex‑wage). Rural rates and higher use (up to the statutory caps) would scale costs materially. (Author’s calculation using statutory multipliers.)

Social Effects

• Patient experience and quality of life: Compared with in‑center HD, home modalities are associated with small but measurable gains in health‑related quality of life; adding time‑limited staff assistance and early psychosocial care plausibly supports smoother home starts. [5]American Journal of Kidney Diseases (via PMC) — Health‑Related Quality of Life…
• Early psychosocial support: Randomized and controlled studies (e.g., TĀCcare; HED‑Start) and meta‑analyses indicate psychosocial interventions can reduce depressive symptoms and improve selected patient‑reported outcomes during dialysis, though evidence certainty and effect sizes vary. Embedding such services in the first 60 days targets a high‑stress transition. [6]pmc.ncbi.nlm.nih.gov
• Caregiver burden: Home dialysis can shift workload to families; respite assistance may mitigate strain. Systematic reviews across chronic conditions show mixed but sometimes positive effects of respite on caregiver burden—underscoring the need for clear eligibility and outcome tracking in ESRD. [7]pmc.ncbi.nlm.nih.gov
• Equity: Racial/ethnic disparities in home‑dialysis use persist. Unless targeted to underserved patients and monitored for access, new add‑ons could preferentially benefit practices already positioned for home programs, widening gaps. [8]Clinical Journal of the American Society of Nephrology (via PMC) — Racial and E…

Environmental Effects

• Travel emissions: Shifting care from facilities to homes reduces repeated patient travel—a material component of in‑center HD’s carbon footprint—potentially lowering transport‑related emissions. [9]Frontiers in Medicine (via PMC) — Incremental Peritoneal Dialysis: less is more…
• Resource use at home: Home HD still consumes substantial water/energy; PD generates high single‑use plastic waste. Reviews highlight both the heavy resource intensity of dialysis and emerging mitigation strategies (e.g., recycling pilots for PD plastics). Net environmental effect depends on local travel patterns, modality mix, and waste handling. [10]Nature Reviews Nephrology — Water use in dialysis: environmental considerations
• Program design lever: By making home starts more viable, the bill could nudge modality mix in ways that trade travel emissions for household resource use. Agencies should pair implementation with sustainability guidance (e.g., water‑saving devices, plastic recycling) and measure results. [11]nature.com

Temporal Analysis

1. Short term (2028–2030, initial implementation): Facilities stand up staffing and workflows; earliest benefits likely in patient‑reported outcomes (less distress; smoother home transitions) and caregiver relief; spending rises via add‑ons; measurable shifts in home‑dialysis penetration uncertain given past payment experiments. [6]pmc.ncbi.nlm.nih.gov
2. Medium term (3–5 years): If respite/psychosocial supports reduce technique failure or prevent temporary returns to in‑center HD, utilization and hospitalization patterns may improve; otherwise effects plateau at higher cost. Ongoing evaluation should stratify by rurality and demographics to detect inequities. [5]American Journal of Kidney Diseases (via PMC) — Health‑Related Quality of Life…
3. Long term (5+ years): Workforce capacity, technology, and complementary CMS models (e.g., KCC/ETC refinements) will determine sustained impact on modality mix and outcomes. [12]cms.gov

Unintended Consequences and Risks

• Workforce constraints: Qualified personnel (RNs, LPNs, certified patient care technicians, dialysis social workers) are finite; rapid uptake could strain staffing, especially in rural areas the bill intends to favor. [1]U.S. House of Representatives — H.R. 8875 (IH) – Improving Home Dialysis Act of…
• Quality/oversight: CMS guidance permits staff‑assisted home dialysis under facility oversight; scaling in the home elevates infection‑control and competency verification needs. [13]Centers for Medicare & Medicaid Services — CMS State Operations Manual – ESRD g…
• Equity inversion: Providers with mature home programs could capture add‑ons first, leaving safety‑net communities behind unless implementation includes targeted technical assistance and monitoring. [8]Clinical Journal of the American Society of Nephrology (via PMC) — Racial and E…
• Effectiveness uncertainty: Evidence linking early psychosocial care to hard endpoints (hospitalization, survival) remains limited; benefits may concentrate in patient‑reported outcomes. [14]pmc.ncbi.nlm.nih.gov

Assessment

Bottom line: Neutral to cautiously favorable. The bill targets two documented barriers to durable home dialysis—early psychological distress and short‑term loss of self‑care capacity—using time‑limited, well‑scoped supports and established personnel standards. Expected near‑term gains are in patient experience and caregiver relief; system savings are uncertain and hinge on disciplined implementation, equity safeguards, and workforce investment. [1]U.S. House of Representatives — H.R. 8875 (IH) – Improving Home Dialysis Act of…

Sourcing (key references)

Selected authoritative materials that underpin the analysis above.

• Bill text and committee action: H.R. 8875 bill PDF; Ways & Means vote record (28–13 on May 21, 2026). [1]U.S. House of Representatives — H.R. 8875 (IH) – Improving Home Dialysis Act of…
• Regulatory cross‑references: 42 CFR 494.90 (psychosocial services); 42 CFR 494.140 (personnel qualifications); CMS State Operations Manual guidance on staff‑assisted home dialysis. [15]Legal Information Institute (Cornell Law) — 42 CFR 494.90 – Patient plan of car…
• Payment context: CMS CY2025 ESRD PPS fact sheet; Federal Register/related materials referencing the home/self‑dialysis training add‑on (e.g., $95.60). [16]Centers for Medicare & Medicaid Services — CY 2025 ESRD PPS Final Rule – CMS Fa…
• Outcomes and disparities: HRQoL meta‑analysis showing small QoL gains for home modalities; studies on racial/ethnic disparities in home‑dialysis use. [5]American Journal of Kidney Diseases (via PMC) — Health‑Related Quality of Life…
• Environmental footprint: Reviews on dialysis resource use and carbon emissions; PD plastic‑recycling pilots. [9]Frontiers in Medicine (via PMC) — Incremental Peritoneal Dialysis: less is more…
• Program‑effect signals: ETC Model evaluation “Findings at a Glance” through 2022 (no differential home‑dialysis growth vs. comparisons). [17]CMS Innovation Center — ETC Model Evaluation – Findings at a Glance (through De…
• Baseline prevalence: USRDS‑linked NKF fact sheet summarizing 2021 modality counts. [18]National Kidney Foundation — Kidney Disease Fact Sheet (includes USRDS 2021 mod…